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ABSTRACT 
Infectious diseases raise consciousness of our global liability and the aptitude of mankind to prepare medicinally significant 
molecules during the past century has lead to decrease in the mortality rate from numerous infectious diseases. Benzotriazole 
derivatives have showed activities like antibacterial, antifungal, antiviral, antiprotozoal and anthelmentic action. These investigations 
propose the option of emerging a lead compound of benzotriazole having a potential antifungal activity. Molecular docking 
simulation based virtual screening with ligand library having benzotriazole derivatives have been performed to identify possible lead 
molecules to inhibit 1EA1.pdb & 1IYL.pdb receptor for treatment of fungal infection. Further the docked conformation of ligand 
should be perfectly overlayed with the crystal structure of the downloaded protein. This testing is completed successful and the 
docked confirmation of the fluconazole is perfectly superimposed with reference structure of fluconazole used by the Autodock 
docking algorithm. 
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INTRODUCTION: 
Infectious disease are of major concern now a days as 
the infectious diseases are responsible for more than 9.5 
million deaths people around the world. Infectious 
diseases are also destructive to the health of adults, 
causing disability, a diminished quality of life, decreased 
productivity or death. Co-infection is also a matter of 
great concern as people infected with one infectious 
disease become more susceptible to other diseases. 
Examples include: HIV/AIDS co-infection with 
tuberculosis or malaria. Treatment of these infections 
with rapid development of resistance in organisms has 
added fuel to worsened situation. 
Recent study showed that several benzotriazole and 
1,2,4-triazole derivatives represented an interesting class 
of heterocycle and became the most rapidly expanding 
group of antifungal compounds with the advantage of 
low toxicity, high oral bioavailability and broad 
spectrum activity. Moreover, a variety of benzotriazoles 
have been reported to inhibit the growth of some 
microorganisms and some benzotriazole derivatives 
show anti-inflammatory properties. Benzotriazole 
moiety has distinct property on biological system as 
antifungal, antibacterial, diuretics etc. Benzotriazole, 
benzimidazole and Imidazole moiety and to screen their 
diverse activity like antifungal, anti-inflammatory and 
antimicrobial activity. Tuberculosis is also the top most 
cause for the death of HIV-infected individuals, as 
immune compromised HIV-infected individuals are 
highly prone to get infected with Mycobacterium 
tuberculosis bacteria 
1
. Multi drug-resistant tuberculosis 
(MDR-TB) plus resistance to a fluoroquinolone and at 
least one second-line injectable agent, such as amikacin, 
kanamycin and/or capreomycin, is called extensively 
drug-resistant TB (XDR-TB) 
2-3
. 
MATERIALS AND METHODS: 
The compounds were designed on the basis of virtual 
screening and quantitative structure activity relationship 
studies.
4 
The designed benzotriazole compounds  was  
validated by molecular docking simulations using 
Molegro as docking tool on various receptor model like 
1EA1.pdb and 1IYL.pdb obtained from Brookhaven 
Protein Data Bank (http://www.rcsb.org/pdb). 
Molecular docking simulations of designed 
compounds 
All the calculations were carried out by using Molegro 
as docking tool. The visualization and other programs 
necessary for docking studies were performed out by 
means of Pymol, Chimera, DS visualizer, MMP Plus. 
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Docking of MTCYP51 complex 
Docking studies was performed with crystal structure 
(1EA1 & 1IYL) of protein consisting of receptor 
associated with bound ligand for antifungal activity of 
the designed compounds.  
Crystal structure of 1EA1 & 1IYL.pdb 
The crystal structures of the protein consisting of 
receptor associated with bound ligand is downloaded 
from the Protein Data Bank portal. All the primary 
information regarding receptor and structure (1EA1.pdb 
& pdb id: 1IYL) registered in the Protein data bank was 
used (Figure 1 & 2). 
 
                   
Figure 1: Crystal structure of 1EA1.pdb              Figure 2: Crystal structure of 1IYL.pdb 
 
Processing of Protein  
Receptor Preparation: The X-ray crystal structures of 
(1EA1.pdb & pdb id: 1IYL) was obtained from 
Brookhaven Protein Data Bank 
(http://www.rcsb.org/pdb). Chain A of 1IYL.pdb was 
selected for docking by parsing the protein structure in 
Chimera (UCSF, CA, USA). 
Ligand: The ligand is separated from the 
receptors1EA1.pdb & 1IYL.pdb by the means of 
Chimera software than it was saved as pdb file and then 
this ligand was docked into receptors using the Molegro 
program. 
Grid Box: The regions of interest used by AUTODOCK 
were defined by considering grid area by  
making a grid box around the active sites. Grid box 
plays a central role in process of docking as it is made to 
cover all the amino acids present in active sites 
necessary for binding other than those present in 
receptor. Grid box has 3 thumbwheel widgets which let 
us change the number of points in the x, y and z 
dimension (Figure 5). 
 
Figure 3: Grid box covering all active sites in 
receptor 
Validation of Docking Process 
Internal validation 
To ensure that the ligand orientations and positions 
obtained from the docking studies represent valid and 
reasonable potential binding modes of the inhibitors, the 
docking methods and parameters used were validated by 
redocking the crystallized DCKA and overlaying the 
docked and crystallized DCKA chemical structures and 
calculating the rms value. 
 
                       
Figure 4: 1EA1- ligand interaction rcsb data base             Figure 5: 1IYL.pdb- ligand interaction rcsb data base. 
The internal method validation is performed to obtain 
the orientation of the ligand and fluconazole molecule. 
Further the designed molecules were validated by taking 
the overlay of the three molecules i.e. the ligand, 
fluconazole internal reference and the designed 
molecule to obtain orientation and position of the site of 
attachment to give maximum effect. 
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Figure 6: 1IYL.pdb- ligand, fluconazole & designed 
interaction rcsb data base. 
RESULT & DISCUSSION: 
Docking Studies 
To strengthen the designing of the compounds further 
the docking studies were performed of the designed 
compounds. For the docking studies the protein 
molecule selected for inhibition was 1EA1.pdb and 
1IYL.pdb was into consideration. The docking studies 
were performed using Molgro Virtual Docker (MVD) 
software. All the compounds as well as fluconazole 
were docked into the active site of 14a-demethylase 
which was obtained from Protein Data Bank  using 
molegro virtual docker. Docking score showed that 
these compounds docked to the active site of the enzyme 
comparable to fluconazole. All new azole compounds 
plus fluconazole were characterized by a docking mode 
in the active site of the cytochrome P450 14a-sterol 
demethylase. 
 
Table 1: Docking studies of designed compounds. 
Comp. 
No. 
Benztriazole Analogs 
1EA1.pdb 1IYL.pdb 
MolDock 
Score 
Rerank 
Score 
MolDock 
Score 
Rerank 
Score 
MRK2 
N-(4-chloro-2-nitrophenyl)-1H-
benzo[d][1,2,3]triazole-5-carboxamide 
-124.826 -102.933 -127.367 -104.427 
MRK3 
N-(2,4-dinitrophenyl)-1H-
benzo[d][1,2,3]triazole-5-carboxamide 
-132.387 -100.089 -130.291 -108.232 
MRK7 
N-(4-aminophenylsulfonyl)-1H-
benzo[d][1,2,3]triazole-5-carboxamide 
-115.437 -94.3645 -126.319 -107.959 
MRK8 
N-(2,6-dimethylphenyl)-1H-
benzo[d][1,2,3]triazole-5-carboxamide 
-119.713 -100.962 -119.246 -99.8017 
MRK9 
N-(4-nitrophenyl)-1H-
benzo[d][1,2,3]triazole-5-carboxamide 
-118.428 -96.2889 -122.037 -102.098 
MRK11 
N-((1H-benzo[d][1,2,3]triazol-1-
yl)methyl)-2-chloro-4-nitrobenzenamine 
-119.276 -97.7265 -121.333 -102.304 
MRK12 
N-((1H-benzo[d][1,2,3]triazol-1-
yl)methyl)-4-chloro-2-nitrobenzenamine 
-123.532 -97.9336 -126.359 -102.057 
MRK13 
N-((1H-benzo[d][1,2,3]triazol-1-
yl)methyl)-2,4-dinitrobenzenamine 
-119.554 -96.4469 -130.782 -106.987 
MRK19 
N-((1H-benzo[d][1,2,3]triazol-1-
yl)methyl)-4-nitrobenzenamine 
-118.188 -95.8836 -130.981 -103.662 
 
CONCLUSION: 
There is some correlation between antifungal activity 
and docking energy. Thus for the compounds MRK02, 
MRK03, MRK07, MRK09, MRK11, MRK12 and 
MRK19 show potent growth inhibition and have good 
docking energy. All of these compounds are found to be 
active but docking studies shows that compound 3 and 
19 are the most active compounds with better biological 
activity.
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